Big Pharma would rather buy back than pay forward
May 07, 2015 at 13:35 PM EDT
Big Pharma is cutting back on basic research while spending more money on share buybacks, writes Jim O’Neill.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.